Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s obesity drug candidate "EPPE" has...
Search results for "GLP-1 drugs"
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, for its next-generation...
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal
Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop...
The Ozempic Multiplier: Why Lifestyle Habits Still Dictate Heart Health in the GLP-1 Era
It has been three months since I started my once-weekly Ozempic injection. My blood sugar is clearly under control, and...
Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
Can Wegovy and Mounjaro Reduce Cancer Risk?
Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'
"Please lose some weight. " This is a common phrase heard when visiting a hospital for knee pain.
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity
It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.
Why ‘Elegant Dining’ Might Be the Secret to Appetite Control
If you typically rush through a sandwich at your desk or eat in a chaotic environment, you might be missing out on a...